WHO WE ARE
iQure Pharma is uniquely positioned in developing new therapeutics solutions by bridging inventions stemming mostly from academia research with pharma industry, founded by entrepreneurs with strong pharmaceutical and financial industry background.
OUR CORE COMPETENCIES
Scouting for innovative compounds coming out of research from unmined academic sources.
Evaluating out-licensing opportunities with big pharma and biotech for medical and commercial attractive targets.
Selecting from that pool those compounds with a significant attractive target profile, which can support a future commercialization process.
Driving and leading preclinical and clinical development activities, ensuring regulatory and quality compliance in all development tasks, while never losing focus on the final beneficiaries’ needs: the patients.
Securing the required investment activities by assisting our investors in placing their funding in the most commercially viable therapies with attractive market potential and addressing clearly defined clinical needs.
Location: United States, Delaware, Wilmington
Member count: 1-10
Total raised: $600K
Founded date: 2019
Investors 1
| Date | Name | Website |
| 28.07.2023 | Keiretsu Forum | keiretsuforum.... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 31.08.2022 | Series A | $600K | - | finsmes.com/20... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 31.08.2022 | iQure Pharma R... | iQure Pharma, a Princeton, NJ-based biotech company, raised $600K in Early Closing as part of its Se... | finsmes.com/20... |